Michael Ehlers
Neuroscience Chief Scientific Officer
Pfizer
From this contributor
A cautionary tale for autism drug development
Poorly designed animal drug studies for motor disorders have led to spurious conclusions for the clinical trials that follow. This may be even more true for autism research, says Michael Ehlers.
SHANK mutations converge at neuronal junctions in autism
SHANK3, one of the strongest candidate genes for autism, has the potential to be a molecular entry point into understanding the synaptic, developmental and circuit origins of the disorder.
SHANK mutations converge at neuronal junctions in autism
Drug zone
Rodent and stem cell models remain challenging for developing psychiatric drugs, says Michael Ehlers, chief scientific officer of neuroscience at Pfizer.
Explore more from The Transmitter
How basic neuroscientists can connect with autistic people and their communities
A first-of-its-kind workshop offers a template for autism researchers who want to incorporate community perspectives into their work.
How basic neuroscientists can connect with autistic people and their communities
A first-of-its-kind workshop offers a template for autism researchers who want to incorporate community perspectives into their work.
Long-sought walking circuit found in fruit flies
The neuronal circuit controlling repetitive locomotion patterns in any animal has been a mystery until now.
Long-sought walking circuit found in fruit flies
The neuronal circuit controlling repetitive locomotion patterns in any animal has been a mystery until now.
Crisis de financiación en Argentina desata nueva ola de protestas
Dos años luego de que colapsara la financiación para investigación del país colapsara, los científicos están manifestando en contra del incumplimiento del gobierno para restaurar becas cortadas previamente y aumentar salarios como lo establece una del 2025.
Crisis de financiación en Argentina desata nueva ola de protestas
Dos años luego de que colapsara la financiación para investigación del país colapsara, los científicos están manifestando en contra del incumplimiento del gobierno para restaurar becas cortadas previamente y aumentar salarios como lo establece una del 2025.